Bax, Bak and beyond — mitochondrial performance in apoptosis

FEBS Journal

Volumn 285, Issue 3, 2018, Pages 416-431

  Peña Blanco, Aida ^a   García Sáez, Ana J ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR INTELLIGENT SYSTEMS   (Germany)

Author keywords

apoptosis; BAK; BAX; BCL 2 family; DRP1; mitochondria; mitochondrial outer membrane permeabilization

Indexed keywords

BH3 PROTEIN; DIMER; OLIGOMER; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BOK; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAK1 PROTEIN, HUMAN; BAX PROTEIN, HUMAN; C22ORF29 PROTEIN, HUMAN;

APOPTOSIS; CELL PERMEABILIZATION; CHANNEL GATING; DIMERIZATION; LIPID COMPOSITION; MACROMOLECULE; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; OLIGOMERIZATION; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; AGONISTS; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; ENZYMOLOGY; HUMAN; LIPID BILAYER; LIPID METABOLISM; METABOLISM; MITOCHONDRIAL MEMBRANE; POROSITY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; DIMERIZATION; HUMANS; LIPID BILAYERS; LIPID MOBILIZATION; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANES; MODELS, BIOLOGICAL; POROSITY; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 85028880684     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.14186     Document Type: Review

References (130)

1. Czabotar PE, Lessene G, Strasser A & Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15, 49–63.
2. Delbridge AR, Grabow S, Strasser A & Vaux DL (2016) Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 16, 99–109.
3. Strasser A, Cory S & Adams JM (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30, 3667–3683.
4. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ & Green DR (2010) The BCL-2 family reunion. Mol Cell 37, 299–310.
5. Tait SW & Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11, 621–632.
6. Garcia-Saez AJ (2012) The secrets of the Bcl-2 family. Cell Death Differ 19, 1733–1740.
7. Youle RJ & Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9, 47–59.
8. Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C, Neutzner A, Tjandra N & Youle RJ (2011) Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell 145, 104–116.
9. Todt F, Cakir Z, Reichenbach F, Emschermann F, Lauterwasser J, Kaiser A, Ichim G, Tait SW, Frank S, Langer HF et al. (2015) Differential retrotranslocation of mitochondrial Bax and Bak. EMBO J 34, 67–80.
10. Schellenberg B, Wang P, Keeble JA, Rodriguez-Enriquez R, Walker S, Owens TW, Foster F, Tanianis-Hughes J, Brennan K, Streuli CH et al. (2013) Bax exists in a dynamic equilibrium between the cytosol and mitochondria to control apoptotic priming. Mol Cell 49, 959–971.
11. Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, Leber B & Andrews DW (2008) Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135, 1074–1084.
12. Hsu YT, Wolter KG & Youle RJ (1997) Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 94, 3668–3672.
13. Dlugosz PJ, Billen LP, Annis MG, Zhu W, Zhang Z, Lin J, Leber B & Andrews DW (2006) Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J, 25, 2287–2296.
14. Martinou JC & Youle RJ (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21, 92–101.
15. Prudent J & McBride HM (2017) The mitochondria-endoplasmic reticulum contact sites: a signalling platform for cell death. Curr Opin Cell Biol 47, 52–63.
16. Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J & Voeltz GK (2011) ER tubules mark sites of mitochondrial division. Science 334, 358–362.
17. Suzuki M, Youle RJ & Tjandra N (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103, 645–654.
18. Gahl RF, He Y, Yu S & Tjandra N (2014) Conformational rearrangements in the pro-apoptotic protein, Bax, as it inserts into mitochondria: a cellular death switch. J Biol Chem 289, 32871–32882.
19. Garner TP, Reyna DE, Priyadarshi A, Chen HC, Li S, Wu Y, Ganesan YT, Malashkevich VN, Almo SS, Cheng EH et al. (2016) An autoinhibited dimeric form of BAX regulates the BAX activation pathway. Mol Cell 63, 485–497.
20. Griffiths GJ, Dubrez L, Morgan CP, Jones NA, Whitehouse J, Corfe BM, Dive C & Hickman JA (1999) Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol 144, 903–914.
21. Gavathiotis E, Suzuki M, Davis ML, Pitter K, Bird GH, Katz SG, Tu HC, Kim H, Cheng EH, Tjandra N et al. (2008) BAX activation is initiated at a novel interaction site. Nature 455, 1076–1081.
22. Gavathiotis E, Reyna DE, Davis ML, Bird GH & Walensky LD (2010) BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol Cell 40, 481–492.
23. Czabotar PE, Westphal D, Dewson G, Ma S, Hockings C, Fairlie WD, Lee EF, Yao S, Robin AY, Smith BJ et al. (2013) Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell 152, 519–531.
24. Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ & Cheng EH (2009) Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 36, 487–499.
25. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB & Korsmeyer SJ (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14, 2060–2071.
26. Eskes R, Desagher S, Antonsson B & Martinou JC (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20, 929–935.
27. Leshchiner ES, Braun CR, Bird GH & Walensky LD (2013) Direct activation of full-length proapoptotic BAK. Proc Natl Acad Sci USA 110, E963–E995.
28. Dai H, Smith A, Meng XW, Schneider PA, Pang YP & Kaufmann SH (2011) Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization. J Cell Biol 194, 39–48.
29. Li MX, Tan IKL, Ma SB, Hockings C, Kratina T, Dengler MA, Alsop AE, Kluck RM & Dewson G (2017) BAK alpha6 permits activation by BH3-only proteins and homooligomerization via the canonical hydrophobic groove. Proc Natl Acad Sci USA 114, 7629–7634.
30. Iyer S, Anwari K, Alsop AE, Yuen WS, Huang DC, Carroll J, Smith NA, Smith BJ, Dewson G & Kluck RM (2016) Identification of an activation site in Bak and mitochondrial Bax triggered by antibodies. Nat Commun 7, 11734.
31. Subburaj Y, Cosentino K, Axmann M, Pedrueza-Villalmanzo E, Hermann E, Bleicken S, Spatz J & Garcia-Saez AJ (2015) Bax monomers form dimer units in the membrane that further self-assemble into multiple oligomeric species. Nat Commun 6, 8042.
32. Dewson G, Kratina T, Czabotar P, Day CL, Adams JM & Kluck RM (2009) Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Mol Cell 36, 696–703.
33. Uren RT, O'Hely M, Iyer S, Bartolo R, Shi MX, Brouwer JM, Alsop AE, Dewson G & Kluck RM (2017) Disordered clusters of Bak dimers rupture mitochondria during apoptosis. Elife 6, e19944.
34. Brouwer JM, Westphal D, Dewson G, Robin AY, Uren RT, Bartolo R, Thompson GV, Colman PM, Kluck RM & Czabotar PE (2014) Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers. Mol Cell 55, 938–946.
35. Bleicken S, Jeschke G, Stegmueller C, Salvador-Gallego R, Garcia-Saez AJ & Bordignon E (2014) Structural model of active Bax at the membrane. Mol Cell 56, 496–505.
36. Dewson G, Kratina T, Sim HW, Puthalakath H, Adams JM, Colman PM & Kluck RM (2008) To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. Mol Cell 30, 369–380.
37. Dewson G, Ma S, Frederick P, Hockings C, Tan I, Kratina T & Kluck RM (2012) Bax dimerizes via a symmetric BH3:groove interface during apoptosis. Cell Death Differ 19, 661–670.
38. Bleicken S, Classen M, Padmavathi PV, Ishikawa T, Zeth K, Steinhoff HJ & Bordignon E (2010) Molecular details of Bax activation, oligomerization, and membrane insertion. J Biol Chem 285, 6636–6647.
39. Aluvila S, Mandal T, Hustedt E, Fajer P, Choe JY & Oh KJ (2014) Organization of the mitochondrial apoptotic BAK pore: oligomerization of the BAK homodimers. J Biol Chem 289, 2537–2551.
40. Ma S, Hockings C, Anwari K, Kratina T, Fennell S, Lazarou M, Ryan MT, Kluck RM & Dewson G (2013) Assembly of the Bak apoptotic pore: a critical role for the Bak protein alpha6 helix in the multimerization of homodimers during apoptosis. J Biol Chem 288, 26027–26038.
41. Zhang Z, Subramaniam S, Kale J, Liao C, Huang B, Brahmbhatt H, Condon SG, Lapolla SM, Hays FA, Ding J et al. (2016) BH3-in-groove dimerization initiates and helix 9 dimerization expands Bax pore assembly in membranes. EMBO J 35, 208–236.
42. Mandal T, Shin S, Aluvila S, Chen HC, Grieve C, Choe JY, Cheng EH, Hustedt EJ & Oh KJ (2016) Assembly of Bak homodimers into higher order homooligomers in the mitochondrial apoptotic pore. Sci Rep 6, 30763.
43. Pang YP, Dai H, Smith A, Meng XW, Schneider PA & Kaufmann SH (2012) Bak Conformational changes induced by ligand binding: insight into BH3 domain binding and Bak homo-oligomerization. Sci Rep 2, 257.
44. Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E & Saikumar P (2003) Association of Bax and Bak homo-oligomers in mitochondria. Bax requirement for Bak reorganization and cytochrome c release. J Biol Chem 278, 5367–5376.
45. Gilbert RJ, Dalla Serra M, Froelich CJ, Wallace MI & Anderluh G (2014) Membrane pore formation at protein-lipid interfaces. Trends Biochem Sci 39, 510–516.
46. Lee MT, Chen FY & Huang HW (2004) Energetics of pore formation induced by membrane active peptides. Biochemistry 43, 3590–3599.
47. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L & Huang HW (1996) Membrane pores induced by magainin. Biochemistry 35, 13723–13728.
48. Cosentino K & Garcia-Saez AJ (2017) Bax and Bak pores: are we closing the circle? Trends Cell Biol 27, 266–275.
49. Unsay JD, Cosentino K, Sporbeck K & Garcia-Saez AJ (2017) Pro-apoptotic cBid and Bax exhibit distinct membrane remodeling activities: an AFM study. Biochem Biophys Acta 1859, 17–27.
50. Fuertes G, Garcia-Saez AJ, Esteban-Martin S, Gimenez D, Sanchez-Munoz OL, Schwille P & Salgado J (2010) Pores formed by Baxalpha5 relax to a smaller size and keep at equilibrium. Biophys J 99, 2917–2925.
51. Garcia-Saez AJ, Coraiola M, Dalla Serra M, Mingarro I, Menestrina G & Salgado J (2005) Peptides derived from apoptotic Bax and Bid reproduce the poration activity of the parent full-length proteins. Biophys J 88, 3976–3990.
52. Garcia-Saez AJ, Coraiola M, Serra MD, Mingarro I, Muller P & Salgado J (2006) Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores. FEBS J 273, 971–981.
53. Qian S, Wang W, Yang L & Huang HW (2008) Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores. Proc Natl Acad Sci USA 105, 17379–17383.
54. Bleicken S, Landeta O, Landajuela A, Basanez G & Garcia-Saez AJ (2013) Proapoptotic Bax and Bak Proteins form stable protein-permeable pores of tunable size. J Biol Chem 288, 33241–33252.
55. Schafer B, Quispe J, Choudhary V, Chipuk JE, Ajero TG, Du H, Schneiter R & Kuwana T (2009) Mitochondrial outer membrane proteins assist Bid in Bax-mediated lipidic pore formation. Mol Biol Cell 20, 2276–2285.
56. Salvador-Gallego R, Mund M, Cosentino K, Schneider J, Unsay J, Schraermeyer U, Engelhardt J, Ries J & Garcia-Saez AJ (2016) Bax assembly into rings and arcs in apoptotic mitochondria is linked to membrane pores. EMBO J 35, 389–401.
57. Grosse L, Wurm CA, Bruser C, Neumann D, Jans DC & Jakobs S (2016) Bax assembles into large ring-like structures remodeling the mitochondrial outer membrane in apoptosis. EMBO J 35, 402–413.
58. Kuwana T, Olson NH, Kiosses WB, Peters B & Newmeyer DD (2016) Pro-apoptotic Bax molecules densely populate the edges of membrane pores. Sci Rep 6, 27299.
59. Xu XP, Zhai D, Kim E, Swift M, Reed JC, Volkmann N & Hanein D (2013) Three-dimensional structure of Bax-mediated pores in membrane bilayers. Cell Death Dis 4, e683.
60. Nasu Y, Benke A, Arakawa S, Yoshida GJ, Kawamura G, Manley S, Shimizu S & Ozawa T (2016) In situ characterization of bak clusters responsible for cell death using single molecule localization microscopy. Sci Rep 6, 27505.
61. Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B & Andrews DW (2005) Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J 24, 2096–2103.
62. Westphal D, Dewson G, Menard M, Frederick P, Iyer S, Bartolo R, Gibson L, Czabotar PE, Smith BJ, Adams JM et al. (2014) Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane. Proc Natl Acad Sci USA 111, E4076–E4085.
63. Uren RT, Dewson G, Chen L, Coyne SC, Huang DC, Adams JM & Kluck RM (2007) Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol 177, 277–287.
64. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM & Huang DC (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19, 1294–1305.
65. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P et al. (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856–859.
66. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S & Korsmeyer SJ (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183–192.
67. Moreau C, Cartron PF, Hunt A, Meflah K, Green DR, Evan G, Vallette FM & Juin P (2003) Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins. J Biol Chem 278, 19426–19435.
68. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR & Newmeyer DD (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17, 525–535.
69. Leber B, Lin J & Andrews DW (2007) Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 12, 897–911.
70. Leber B, Lin J & Andrews DW (2010) Still embedded together binding to membranes regulates Bcl-2 protein interactions. Oncogene 29, 5221–5230.
71. Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL, Dillon CP & Green DR (2011) A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell 44, 517–531.
72. Chen HC, Kanai M, Inoue-Yamauchi A, Tu HC, Huang Y, Ren D, Kim H, Takeda S, Reyna DE, Chan PM et al. (2015) An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nat Cell Biol 17, 1270–1281.
73. O'Neill KL, Huang K, Zhang J, Chen Y & Luo X (2016) Inactivation of prosurvival Bcl-2 proteins activates Bax/Bak through the outer mitochondrial membrane. Genes Dev 30, 973–988.
74. Huber HJ, Duessmann H, Wenus J, Kilbride SM & Prehn JH (2011) Mathematical modelling of the mitochondrial apoptosis pathway. Biochem Biophys Acta 1813, 608–615.
75. Zhang T, Brazhnik P & Tyson JJ (2009) Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death. Biophys J 97, 415–434.
76. Rehm M, Huber HJ, Dussmann H & Prehn JH (2006) Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J 25, 4338–4349.
77. Rehm M, Huber HJ, Hellwig CT, Anguissola S, Dussmann H & Prehn JH (2009) Dynamics of outer mitochondrial membrane permeabilization during apoptosis. Cell Death Differ 16, 613–623.
78. Dussmann H, Rehm M, Concannon CG, Anguissola S, Wurstle M, Kacmar S, Voller P, Huber HJ & Prehn JH (2010) Single-cell quantification of Bax activation and mathematical modelling suggest pore formation on minimal mitochondrial Bax accumulation. Cell Death Differ 17, 278–290.
79. Bleicken S, Hantusch A, Das KK, Frickey T & Garcia-Saez AJ (2017) Quantitative interactome of a membrane Bcl-2 network identifies a hierarchy of complexes for apoptosis regulation. Nat Commun 8, 73.
80. Hinds MG, Smits C, Fredericks-Short R, Risk JM, Bailey M, Huang DC & Day CL (2007) Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 14, 128–136.
81. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM & Huang DC (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17, 393–403.
82. Aranovich A, Liu Q, Collins T, Geng F, Dixit S, Leber B & Andrews DW (2012) Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Mol Cell 45, 754–763.
83. Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, Chen J, Dayton BD, Ding H, Enschede SH, Fairbrother WJ et al. (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19, 202–208.
84. Certo M, Del Gaizo Moore V, Nishino M, Wei G, Korsmeyer S, Armstrong SA & Letai A (2006) Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell 9, 351–365.
85. Garcia-Saez AJ, Ries J, Orzaez M, Perez-Paya E & Schwille P (2009) Membrane promotes tBID interaction with BCL(XL). Nat Struct Mol Biol 16, 1178–1185.
86. Das KK, Shalaby R & Garcia-Saez AJ (2017) Determinants of BH3 Sequence Specificity for the Disruption of Bcl-xL/cBid Complexes in Membranes. ACS Chem Biol 12, 989–1000.
87. Hockings C, Anwari K, Ninnis RL, Brouwer J, O'Hely M, Evangelista M, Hinds MG, Czabotar PE, Lee EF, Fairlie WD et al. (2015) Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax. Cell Death Dis 6, e1735.
88. Sarosiek KA, Chi X, Bachman JA, Sims JJ, Montero J, Patel L, Flanagan A, Andrews DW, Sorger P & Letai A (2013) BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response. Mol Cell 51, 751–765.
89. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB & Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727–730.
90. Echeverry N, Bachmann D, Ke F, Strasser A, Simon HU & Kaufmann T (2013) Intracellular localization of the BCL-2 family member BOK and functional implications. Cell Death Differ 20, 785–799.
91. Llambi F, Wang YM, Victor B, Yang M, Schneider DM, Gingras S, Parsons MJ, Zheng JH, Brown SA, Pelletier S et al. (2016) BOK is a non-canonical BCL-2 family effector of apoptosis regulated by ER-associated degradation. Cell 165, 421–433.
92. Einsele-Scholz S, Malmsheimer S, Bertram K, Stehle D, Johänning J, Manz M, Daniel PT, Gillissen BF, Schulze-Osthoff K & Essmann F (2016) Bok is a genuine multi-BH-domain protein that triggers apoptosis in the absence of Bax and Bak. J Cell Sci 129, 3054.
93. Fernandez-Marrero Y, Bleicken S, Das KK, Bachmann D, Kaufmann T & Garcia-Saez AJ (2017) The membrane activity of BOK involves formation of large, stable toroidal pores and is promoted by cBID. FEBS J 284, 711–724.
94. Saita S, Nolte H, Fiedler KU, Kashkar H, Venne AS, Zahedi RP, Kruger M & Langer T (2017) PARL mediates Smac proteolytic maturation in mitochondria to promote apoptosis. Nat Cell Biol 19, 318–328.
95. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA & Korsmeyer SJ (2002) A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2, 55–67.
96. White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, van Delft MF, Bedoui S, Lessene G, Ritchie ME et al. (2014) Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549–1562.
97. Rongvaux A, Jackson R, Harman CC, Li T, West AP, de Zoete MR, Wu Y, Yordy B, Lakhani SA, Kuan CY et al. (2014) Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563–1577.
98. Nechushtan A, Smith CL, Lamensdorf I, Yoon SH & Youle RJ (2001) Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J Cell Biol 153, 1265–1276.
99. Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A, Santel A, Fuller M, Smith CL & Youle RJ (2002) Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 159, 931–938.
100. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL & Youle RJ (2001) The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2, 515–525.
101. Rowland AA & Voeltz GK (2012) Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol 13, 607–625.
102. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR et al. (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14, 193–204.
103. Estaquier J & Arnoult D (2007) Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ 14, 1086–1094.
104. Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, Otera H, Nakanishi Y, Nonaka I, Goto Y et al. (2009) Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 11, 958–966.
105. Parone PA, James DI, Da Cruz S, Mattenberger Y, Donze O, Barja F & Martinou JC (2006) Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis. Mol Cell Biol 26, 7397–7408.
106. Sheridan C, Delivani P, Cullen SP & Martin SJ (2008) Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol Cell 31, 570–585.
107. Lee YJ, Jeong SY, Karbowski M, Smith CL & Youle RJ (2004) Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 15, 5001–5011.
108. Germain M, Mathai JP, McBride HM & Shore GC (2005) Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J 24, 1546–1556.
109. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B et al. (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177–189.
110. Otera H, Miyata N, Kuge O & Mihara K (2016) Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic cristae remodeling. J Cell Biol 212, 531–544.
111. Prudent J, Zunino R, Sugiura A, Mattie S, Shore GC & McBride HM (2015) MAPL SUMOylation of Drp1 Stabilizes an ER/Mitochondrial Platform Required for Cell Death. Mol Cell 59, 941–955.
112. Wasiak S, Zunino R & McBride HM (2007) Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 177, 439–450.
113. Cosentino K & Garcia-Saez AJ (2014) Mitochondrial alterations in apoptosis. Chem Phys Lipids 181, 62–75.
114. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR & Newmeyer DD (2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331–342.
115. Terrones O, Antonsson B, Yamaguchi H, Wang HG, Liu J, Lee RM, Herrmann A & Basanez G (2004) Lipidic pore formation by the concerted action of proapoptotic BAX and tBID. J Biol Chem 279, 30081–30091.
116. Landeta O, Landajuela A, Gil D, Taneva S, Di Primo C, Sot B, Valle M, Frolov VA & Basanez G (2011) Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane permeabilization process. J Biol Chem 286, 8213–8230.
117. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ, Petit PX, Vaz FM & Gottlieb E (2008) Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 183, 681–696.
118. Lutter M, Perkins GA & Wang X (2001) The pro-apoptotic Bcl-2 family member tBid localizes to mitochondrial contact sites. BMC Cell Biol 2, 22.
119. Zaltsman Y, Shachnai L, Yivgi-Ohana N, Schwarz M, Maryanovich M, Houtkooper RH, Vaz FM, De Leonardis F, Fiermonte G, Palmieri F et al. (2010) MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. Nat Cell Biol 12, 553–562.
120. Dai Q, Liu J, Chen J, Durrant D, McIntyre TM & Lee RM (2004) Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin. Oncogene 23, 3650–3658.
121. Ganesan V, Perera MN, Colombini D, Datskovskiy D, Chadha K & Colombini M (2010) Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane. Apoptosis 15, 553–562.
122. Tafesse FG, Vacaru AM, Bosma EF, Hermansson M, Jain A, Hilderink A, Somerharju P & Holthuis JC (2014) Sphingomyelin synthase-related protein SMSr is a suppressor of ceramide-induced mitochondrial apoptosis. J Cell Sci 127, 445–454.
123. Jain A, Beutel O, Ebell K, Korneev S & Holthuis JC (2017) Diverting CERT-mediated ceramide transport to mitochondria triggers Bax-dependent apoptosis. J Cell Sci 130, 360–371.
124. Siskind LJ, Mullen TD, Romero Rosales K, Clarke CJ, Hernandez-Corbacho MJ, Edinger AL & Obeid LM (2010) The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis. J Biol Chem 285, 11818–11826.
125. Beverly LJ, Howell LA, Hernandez-Corbacho M, Casson L, Chipuk JE & Siskind LJ (2013) BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins. Biochem J 452, 111–119.
126. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM & Green DR (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148, 988–1000.
127. Jensen SA, Calvert AE, Volpert G, Kouri FM, Hurley LA, Luciano JP, Wu Y, Chalastanis A, Futerman AH & Stegh AH (2014) Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci USA 111, 5682–5687.
128. Renault TT, Floros KV, Elkholi R, Corrigan KA, Kushnareva Y, Wieder SY, Lindtner C, Serasinghe MN, Asciolla JJ, Buettner C et al. (2015) Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis. Mol Cell 57, 69–82.
129. Bleicken S, Hofhaus G, Ugarte-Uribe B, Schroder R & Garcia-Saez AJ (2016) cBid, Bax and Bcl-xL exhibit opposite membrane remodeling activities. Cell Death Dis 7, e2121.
130. Montessuit S, Somasekharan SP, Terrones O, Lucken-Ardjomande S, Herzig S, Schwarzenbacher R, Manstein DJ, Bossy-Wetzel E, Basanez G, Meda P et al. (2010) Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 142, 889–901.